FMT for Crohn's disease (FEMTRAC) study
Phase 2
Recruiting
- Conditions
- Crohn's diseaseD003424
- Registration Number
- JPRN-jRCTs041190022
- Lead Sponsor
- Ohmiya Naoki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with active Crohn's disease (CDAI 150 or more)
Exclusion Criteria
1.past history of allergy to drugs used in this study
2.possible of documented pregnant women
3.patients with fistula, penetration, and perforation except anal fistula
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of CDAI score
- Secondary Outcome Measures
Name Time Method 1. IBDQ <br>2. modified SESCD <br>3. hydrogen and methane level in glucose breath test <br>4. urine lactulose mannnitol ratio <br>5. change in fecal microbiome and metabolome